Lessons learned and paths forward: Navigating the social landscape of multiple sclerosis care in the second wave of COVID-19

Nazire Pınar Acar Ozen, Dilara Cilizoglu, Bernanur Toprak, Nartan Demirok, Yeliz Salci, Rana Karabudak, Umut Beşpinar, Aslı Tuncer

DOI: 10.55697/tnd.2025.347

Issue: 2025, Volume 31 - Issue 2
664 427

Alemtuzumab-induced antineutrophil cytoplasmic antibody-associated nephritis in a patient with multiple sclerosis

Furkan Sarıdaş, Saide Elif Güllülü Boz, Belkıs Nihan Coşkun, Emine Rabia Koç, Abdulmecit Yıldız, Berna Aytaç Vuruşkan, Ömer Faruk Turan

DOI: 10.55697/tnd.2024.238

Issue: 2025, Volume 31 - Issue 2
643 405

Redefining multiple sclerosis: 2024 McDonald diagnostic criteria

Hazal Ceren Manazoğlu, Murat Kürtüncü

DOI: 10.55697/tnd.2025.500

Issue: 2025, Volume 31 - Issue 3
1134 611

Association of lifestyle, psychological, and biological risk factors with multiple sclerosis: A case-control study

Rahim Aliyev, Aytan Mammadbayli, Rana Shiraliyeva

DOI: 10.55697/tnd.2025.494

Issue: 2025, Volume 31 - Issue 3
202 130

The relationship of pain, disability, and kinesiophobia levels with heart rate variability in patients with migraine: A prospective cross-sectional study

Rabia Tuğba Tekin, Hilal Aslan, Şadiye Gümüşyayla

DOI: 10.55697/tnd.2025.341

Issue: 2025, Volume 31 - Issue 3
149 126

Long-term cladribine experience in relapsing-remitting multiple sclerosis

Ömer Faruk Turan, Furkan Sarıdaş, Emine Rabia Koç

DOI: 10.55697/tnd.2025.293

Issue: 2025, Volume 31 - Issue 3
138 129